What is Hal N Buch, MD?
Led by Dr. Hal N. Buch, Buch Gastroenterology operates as a premier medical facility dedicated to the diagnosis and treatment of complex gastrointestinal disorders. The practice distinguishes itself through a comprehensive service portfolio that includes advanced endoscopic procedures, such as colonoscopy and upper endoscopy, alongside specialized IV vitamin infusion therapy. By maintaining an AAAASF-accredited facility, the organization ensures that patient care meets the highest standards of safety and clinical excellence. With over two decades of professional experience, the practice serves as a critical hub for patients suffering from conditions ranging from acid reflux to Crohn's disease and celiac disease, emphasizing both preventative care and therapeutic intervention.
How much funding has Hal N Buch, MD raised?
Hal N Buch, MD has raised a total of $129K across 1 funding round:
Debt
$129K
Debt (2021): $129K with participation from PPP
Key Investors in Hal N Buch, MD
PPP
Public-Private Partnership
What's next for Hal N Buch, MD?
The influx of capital is expected to catalyze the next phase of growth for Buch Gastroenterology, focusing on the integration of cutting-edge endoscopic technologies and the expansion of patient-facing services. As the practice navigates this late-stage development phase, the strategic allocation of resources will likely prioritize the optimization of clinical workflows and the enhancement of the facility's technological infrastructure. By leveraging this financial backing, Dr. Buch aims to solidify the practice's reputation as a leader in digestive health, ensuring that the facility remains at the forefront of medical innovation while continuing to provide compassionate, patient-centered care to the growing population of Kingston and its surrounding communities.
See full Hal N Buch, MD company page